End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55,900 KRW | -0.18% | -1.06% | -5.57% |
Business Summary
Number of employees: 38
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicine
96.3
%
| 897,366 | 98.7 % | 846,810 | 96.3 % | -5.63% |
Others
7.3
%
| 62,071 | 6.8 % | 64,548 | 7.3 % | +3.99% |
Consolidated Adjustment
-3.6
%
| -50,474 | -5.6 % | -31,577 | -3.6 % | -37.44% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
82.4
%
| 761,452 | 84.8 % | 724,596 | 82.4 % | -4.84% |
Asia
8.7
%
| 96,701 | 10.8 % | 76,151 | 8.7 % | -21.25% |
Europe
6.4
%
| 37,364 | 4.2 % | 56,279 | 6.4 % | +50.62% |
Other
3.9
%
| 34,779 | 3.9 % | 34,469 | 3.9 % | -0.89% |
Consolidated Adjustment
-2.8
%
| -39,133 | -4.4 % | -24,738 | -2.8 % | -36.79% |
Middle East
1.5
%
| 6,793 | 0.8 % | 12,902 | 1.5 % | +89.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sang-Yeon Hwang
CEO | Chief Executive Officer | 53 | - |
Jang-Won Choi
BRD | Director/Board Member | 62 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
Jae-Hoon Yoon
HRO | Human Resources Officer | 58 | - |
Seong-Wook Han
PRN | Corporate Officer/Principal | 53 | 09-12-31 |
Yoon-Han Lee
AUD | Comptroller/Controller/Auditor | 65 | 02-12-31 |
Jang-Han Lee
PRN | Corporate Officer/Principal | 71 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jang-Han Lee
PRN | Corporate Officer/Principal | 71 | - |
Sang-Yeon Hwang
CEO | Chief Executive Officer | 53 | - |
Ja-Min Gu
BRD | Director/Board Member | 60 | - |
Jang-Won Choi
BRD | Director/Board Member | 62 | - |
Jae-Hoon Yoon
HRO | Human Resources Officer | 58 | - |
Chun-Soon Kim
BRD | Director/Board Member | 61 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,009,861 | 2,375,004 ( 47.41 %) | 249,303 ( 4.976 %) | 47.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3,352,101 | 25.44% | 252,965,866 $ | |
CKD BIO CORP. 39.11% | 2,145,328 | 39.11% | 37,796,646 $ |
157,604 | 3.15% | 7,024,388 $ | |
93,802 | 1.56% | 1,930,879 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.57% | 193M | |
+10.73% | 7.96B | |
+8.44% | 7.66B | |
-0.58% | 5.88B | |
-6.11% | 3.72B | |
-13.21% | 3.47B | |
-15.49% | 1.16B | |
+9.98% | 948M | |
-11.42% | 905M | |
-13.08% | 831M |
- Stock Market
- Equities
- A001630 Stock
- Company Chong Kun Dang Holdings Corp.